Child Poisoning Cases Mount as New York's Cannabis Rollout Faces Scrutiny

Pediatric Exposure Data Drives Policy Debate

Poison-control centers across New York reported a measurable uptick in pediatric cannabis exposures since adult-use sales commenced in December 2022, according to state health department data. The New York State Department of Health hasn't released aggregated statistics for 2025 or 2026. But regional poison-control centers in Albany, Syracuse, and New York City each logged double-digit increases in calls involving children under age 5 who ingested edible cannabis products between January 2023 and June 2026.

On a strict reading of the MRTA's packaging requirements—codified at Cannabis Law §68—all edible products must be individually wrapped in child-resistant, opaque packaging and labeled with a universal THC symbol. Unlicensed retailers operating outside the OCM's regulatory perimeter don't comply with these mandates, creating a bifurcated market in which compliant operators face higher packaging costs while illicit sellers distribute products in non-compliant formats.

The enforcement gap is acute. As of July 2026, the OCM has issued fewer than 200 adult-use retail licenses statewide. Estimates of unlicensed storefronts in New York City alone range from 1,500 to 2,000.

Enforcement Authority and Resource Constraints

The OCM's enforcement division operates with a staff of approximately 40 inspectors tasked with monitoring both licensed and unlicensed activity across a state of 20 million residents. By comparison, California's Department of Cannabis Control employed more than 200 enforcement personnel at a similar stage in its rollout.

New York's enforcement toolkit includes civil penalties up to $10,000 per violation and criminal referrals to local district attorneys, but the MRTA doesn't grant the OCM direct cease-and-desist authority over unlicensed retailers. Instead, the agency must coordinate with the New York City Sheriff's Office, the State Police, and municipal code-enforcement units. Critics describe the multi-agency process as slow and fragmented.

In testimony before the State Assembly's Codes Committee in June 2026, OCM Executive Director Chris Alexander acknowledged that the agency's enforcement capacity hasn't kept pace with the proliferation of unlicensed retail, citing budget constraints and staffing delays as primary obstacles.

Revenue Shortfalls and Tax-Structure Concerns

New York collected $87 million in cannabis excise and retail taxes in fiscal year 2025, falling short of the state's $150 million projection by 42 percent. The MRTA imposes a 13 percent retail excise tax plus a 9 percent state sales tax, with an additional THC-based potency tax at the wholesale level. Some industry analysts argue the three-tier structure incentivizes consumers to purchase from unlicensed sellers offering lower prices.

The potency tax, set at 0.5 cents per milligram of THC for flower and 0.8 cents per milligram for concentrates, adds a variable cost that licensed cultivators and processors must absorb or pass downstream. Unlicensed operators face no such burden. Regulatory economists at Cornell University estimate the resulting price differential at 20 to 30 percent in urban markets.

For full background on this story, see the CannIntel topic hub on New York's cannabis rollout.

What's next: the State Assembly is expected to consider amendments to the MRTA's enforcement provisions in the 2027 legislative session, with proposals including expanded OCM cease-and-desist authority and increased funding for regional task forces. The OCM hasn't issued a timeline for when licensed retail density will reach parity with unlicensed activity.